PRO-DEX, INC.

PDEX ·Healthcare, Medical Devices, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
Operating Activities
Net Income $13.7M $9.0M $2.1M $7.1M $4.6M $6.2M $6.1M $4.1M
Depreciation & Amortization $1.4M $1.2M $1.2M $857.0K $726.0K $686.0K $573.0K $438.0K
Depreciation $1.2M $1.1M $1.0M $727.0K $616.0K $609.0K $559.0K $416.0K
Amortization $60.0K $28.0K $28.0K $37.0K $16.0K $14.0K $14.0K $22.0K
Stock-Based Compensation $688.0K $555.0K $605.0K $766.0K $1.3M $901.0K $286.0K $37.0K
Net Cash from Operating Activities $7.2M $-1.7M $6.2M $5.5M $-847.0K $-2.1M $4.9M $3.3M
Investing Activities
Capital Expenditures $483.0K $1.2M $1.6M $1.8M $519.0K $1.4M
Business Acquisitions $6.5M
Net Cash from Investing Activities $3.9M $-238.0K $-2.2M $-885.0K $-1.2M $-3.7M $-2.3M $-1.2M
Financing Activities
Dividends Paid
Stock Repurchases $3.4M $3.5M $3.5M $1.5M $1.6M $5.5M $3.4M $4.0M
Net Cash from Financing Activities $-3.4M $-292.0K $-4.3M $-2.5M $-790.0K $3.1M $-4.0M $450.0K
Net Change in Cash $2.6M
Free Cash Flow $6.8M $-2.9M $-2.5M $-3.8M $4.4M $1.9M
← Newer Page 1 of 2 Older →